NCIRS evaluation of the impact of the national HPV vaccination program has found that HPV vaccination coverage is high and there has been a substantial reduction in the burden of HPV-related disease since the introduction of the vaccine in Australia. It was also found that adverse events following immunisation with HPV vaccine have been predominantly mild and transient in nature, with the vaccine safety record similar to that of other vaccines on the National Immunisation Program. The evaluation makes a range of recommendations to enhance the program and further improve vaccine coverage and equity.

Impact evaluation of national HPV vaccination program_February 2021 Report_0.pdf 2021 Adverse events Human papillomavirus Immunisation coverage Immunisation policy and practice Immunisation reviews Vaccine safety